Table 5 Association between BMI and the risk of eGFR progression among patients with CKD stages 1–3a.

From: Relationship between body mass index and renal function deterioration among the Taiwanese chronic kidney disease population

BMI group

No. of events

Proportion (%)

Study outcome, OR (95% CI)

Unadjusted

P value

Adjusted

P value

BMI < 18.5 (n = 60)

12

20

1.67 (0.86, 3.25)

0.1327

1.42 (0.70–2.88)

0.3325

18.5 ≤ BMI < 24 (n = 752)

98

13

1

—

1

—

24 ≤ BMI < 27 (n = 604)

77

13

0.98 (0.71, 1.34)

0.877

1.06 (0.76–1.47)

0.7474

27 ≤ BMI (n = 592)

71

12

0.91 (0.66, 1.26)

0.5687

0.92 (0.66–1.30)

0.6435

  1. Models were adjusted for age, sex, DM, CAD, Stroke, cancer, hypertension, Charlson score, TB, COPD, ACEI, ARB, fibrate, smoking, alcohol consumption, betel nut chewing, UPCR and eGFR.
  2. OR, odds ratio; CI, confidence interval; BMI, body mass index; DM, diabetes mellitus; CAD, coronary artery disease; CKD; chronic kidney disease; UPCR, urine protein-to-creatinine ratio; eGFR, estimated glomerular filtration rate.
Back to article page